參考文獻 |
1. Feng, L.R. and Maguire-Zeiss, K.A., Gene Therapy in Parkinson’s Disease. Central Nervous System Drugs, 2010. 24(3): p. 177-192.
2. Ni, Y. and Jiang, C., Identification of potential target genes for ankylosing spondylitis treatment. Medicine, 2018. 97(8): p. e9760.
3. Ji, W., Sun, B., and Su, C., Targeting microRNAs in cancer gene therapy. Genes, 2017. 8(1): p. 21.
4. Wiethoff, C.M. and Middaugh, C.R., Barriers to Nonviral Gene Delivery. Journal of Pharmaceutical Sciences, 2003. 92(2): p. 203-217.
5. Futaki, S., Ohashi, W., Suzuki, T., Niwa, M., Tanaka, S., Ueda, K., Harashima, H., and Sugiura, Y., Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chemistry, 2001. 12(6): p. 1005-1011.
6. Nakase, I., Akita, H., Kogure, K., Graslund, A., Langel, U., Harashima, H., and Futaki, S., Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. Accounts of Chemical Research, 2012. 45(7): p. 1132-1139.
7. Tayyab, M. Process Of Recombinant DNA Technology (Genetic Engineering). 2016; Available from: https://simplebiologyy.blogspot.com/2016/02/process-of-recombinant-dna-technology-genetic-engineering.html#comment-form.
8. Al-Dosari, M.S. and Gao, X., Nonviral gene delivery: principle, limitations, and recent progress. The American Association of Pharmaceutical Scientists journal, 2009. 11(4): p. 671-681.
9. Liu, F. and Huang, L., A Syringe Electrode Device for Simultaneous Injection of DNA and Electrotransfer. Molecular Therapy, 2002. 5(3): p. 323-328.
10. Song, Y., Hahn, T., Thompson, I.P., Mason, T.J., Preston, G.M., Li, G., Paniwnyk, L., and Huang, W.E., Ultrasound-mediated DNA transfer for bacteria. Nucleic Acids Research, 2007. 35(19): p. e129.
11. Uchida, M., Natsume, H., Kobayashi, D., Sugibayashi, K., and Morimoto, Y., Effects of particle size, helium gas pressure and microparticle dose on the plasma concentration of indomethacin after bombardment of indomethacin-loaded poly-L-lactic acid microspheres using a Helios gun system. Biological and Pharmaceutical Bulletin, 2002. 25(5): p. 690-693.
12. Tseng, W.C. and Jong, C.M., Improved stability of polycationic vector by dextran-grafted branched polyethylenimine. Biomacromolecules, 2003. 4(5): p. 1277-1284.
13. Xun, M.M., Xiao, Y.P., Zhang, J., Liu, Y.H., Peng, Q., Guo, Q., and Yu, X.Q., Low molecular weight PEI-based polycationic gene vectors via Michael addition polymerization with improved serum-tolerance. Polymer, 2015. 65: p. 45-54.
14. Israelachvili, J.N., Mitchell, D.J., and Ninham, B.W., Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers. Journal of the Chemical Society, Faraday Transactions 2: Molecular and Chemical Physics, 1976. 72(0): p. 1525-1568.
15. Gonzalez-Perez, A. and Persson, K.M., Bioinspired Materials for Water Purification. Materials, 2016. 9(6): p. 447.
16. Yadav D, S.K., Pandey D, Dutta RK, Liposomes for Drug Delivery. Journal of Biotechnology and Biomaterials, 2017. 7(4): p. 1000276.
17. Raffa, V., Vittorio, O., Riggio, C., and Cuschieri, A., Progress in nanotechnology for healthcare. Minimally Invasive Therapy & Allied Technologies, 2010. 19(3): p. 127-135.
18. Neelam Sharma, S.V., Current and future prospective of liposomes as drug delivery vehicles for the effective treatment of cancer. International Journal of Green Pharmacy, 2017. 11(3): p. 377-384.
19. Maestrelli, F., Capasso, G., Gonzalez-Rodriguez, M.L., Rabasco, A.M., Ghelardini, C., and Mura, P., Effect of preparation technique on the properties and in vivo efficacy of benzocaine-loaded ethosomes. Journal of Liposome Research, 2009. 19(4): p. 253-260.
20. Sezer, A.D., Akbuğa, J., and Baş, A.L., In Vitro Evaluation of Enrofloxacin-Loaded MLV Liposomes. Drug Delivery, 2007. 14(1): p. 47-53.
21. Karami, N., Moghimipour, E., and Salimi, A., Liposomes as a novel drug delivery system: fundamental and pharmaceutical application. Asian Journal of Pharmaceutics, 2018. 12(1): p. 31-41.
22. Khoee, S. and Yaghoobian, M., Chapter 6: Niosomes: a novel approach in modern drug delivery systems, in Nanostructures for Drug Delivery-Micro and Nano Technologies. 2017, Elsevier. p. 207-237.
23. Sanarova, E., Lantsova, A., Oborotova, N., Orlova, O., Polozkova, A., Dmitrieva, M., and Nikolaeva, N., Liposome Drug Delivery. Journal of Pharmaceutical Sciences and Research, 2019. 11(3): p. 1148-1155.
24. Schwendener, R.A., Liposomes in biology and medicine. Advances in Experimental Medicine and Biology, 2007. 620: p. 117-128.
25. Resina, S., Prevot, P., and Thierry, A.R., Physico-Chemical Characteristics of Lipoplexes Influence Cell Uptake Mechanisms and Transfection Efficacy. PLOS ONE, 2009. 4(6): p. e6058.
26. Cagdas, M., Sezer, A. D., & Bucak, S., Liposomes as Potential Drug Carrier Systems for Drug Delivery, in Application of Nanotechnology in Drug Delivery. 2014, IntechOpen.
27. Agarwal, R., Iezhitsa, I., Agarwal, P., Abdul Nasir, N.A., Razali, N., Alyautdin, R., and Ismail, N.M., Liposomes in topical ophthalmic drug delivery: an update. Drug Delivery, 2016. 23(4): p. 1075-1091.
28. Bangham, A.D., Standish, M.M., and Watkins, J.C., Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of Molecular Biology, 1965. 13(1): p. 238-252.
29. Gregoriadis, G., Liposome research in drug delivery: The early days. Journal of Drug Targeting, 2008. 16(7-8): p. 520-524.
30. Porteous, D.J., Dorin, J.R., McLachlan, G., Davidson-Smith, H., Davidson, H., Stevenson, B.J., Carothers, A.D., Wallace, W.A., Moralee, S., Hoenes, C., Kallmeyer, G., Michaelis, U., Naujoks, K., Ho, L.P., Samways, J.M., Imrie, M., Greening, A.P., and Innes, J.A., Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy, 1997. 4(3): p. 210-218.
31. Wang, A.Z., Langer, R., and Farokhzad, O.C., Nanoparticle delivery of cancer drugs. The Annual Review of Medicine, 2012. 63: p. 185-198.
32. Barber, R.F. and Shek, P.N., Tear-induced release of liposome-entrapped agents. International Journal of Pharmaceutics, 1990. 60(3): p. 219-227.
33. Barber, R.F. and Shek, P.N., Liposomes and tear fluid. I. Release of vesicle-entrapped carboxyfluorescein. Biochimica et Biophysica Acta, 1986. 879(2): p. 157-163.
34. Li, N., Zhuang, C., Wang, M., Sun, X., Nie, S., and Pan, W., Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. International Journal of Pharmaceutics, 2009. 379(1): p. 131-138.
35. Tan, P.H., Manunta, M., Ardjomand, N., Xue, S.A., Larkin, D.F., Haskard, D.O., Taylor, K.M., and George, A.J., Antibody targeted gene transfer to endothelium. The Journal of Gene Medicine, 2003. 5(4): p. 311-323.
36. Kim, B.K., Hwang, G.B., Seu, Y.B., Choi, J.S., Jin, K.S., and Doh, K.O., DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes. Biochimica et Biophysica Acta, 2015. 1848(10, Part A): p. 1996-2001.
37. Mochizuki, S., Kanegae, N., Nishina, K., Kamikawa, Y., Koiwai, K., Masunaga, H., and Sakurai, K., The role of the helper lipid dioleoylphosphatidylethanolamine (DOPE) for DNA transfection cooperating with a cationic lipid bearing ethylenediamine. Biochimica et Biophysica Acta, 2013. 1828(2): p. 412-418.
38. Trabulo, S., Cardoso, A.L., Mano, M., and De Lima, M.C.P., Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems. Pharmaceuticals (Basel, Switzerland), 2010. 3(4): p. 961-993.
39. Lin, A.J., Slack, N.L., Ahmad, A., George, C.X., Samuel, C.E., and Safinya, C.R., Three-Dimensional Imaging of Lipid Gene-Carriers: Membrane Charge Density Controls Universal Transfection Behavior in Lamellar Cationic Liposome-DNA Complexes. Biophysical Journal, 2003. 84(5): p. 3307-3316.
40. Zauner, W., Ogris, M., and Wagner, E., Polylysine-based transfection systems utilizing receptor-mediated delivery. Advanced Drug Delivery Reviews, 1998. 30(1-3): p. 97-113.
41. Rothbard, J.B., Kreider, E., VanDeusen, C.L., Wright, L., Wylie, B.L., and Wender, P.A., Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. Journal of medicinal chemistry, 2002. 45(17): p. 3612-3618.
42. Vumma, R., Johansson, J., Lewander, T., and Venizelos, N., Tryptophan transport in human fibroblast cells-a functional characterization. International Journal of Tryptophan Research, 2011. 4: p. 19-27.
43. Lindgren, M., Hallbrink, M., Prochiantz, A., and Langel, U., Cell-penetrating peptides. Trends in Pharmacological Sciences, 2000. 21(3): p. 99-103.
44. Shokolenko, I.N., Alexeyev, M.F., LeDoux, S.P., and Wilson, G.L., TAT-mediated protein transduction and targeted delivery of fusion proteins into mitochondria of breast cancer cells. DNA Repair (Amst), 2005. 4(4): p. 511-518.
45. Frankel, A.D. and Pabo, C.O., Cellular uptake of the tat protein from human immunodeficiency virus. Cell, 1988. 55(6): p. 1189-1193.
46. Green, M. and Loewenstein, P.M., Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell, 1988. 55(6): p. 1179-1188.
47. Guidotti, G., Brambilla, L., and Rossi, D., Cell-Penetrating Peptides: From Basic Research to Clinics. Trends in Pharmacological Sciences, 2017. 38(4): p. 406-424.
48. Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., and Prochiantz, A., Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. Journal of Biological Chemistry, 1996. 271(30): p. 18188-18193.
49. Lee, S.H., Castagner, B., and Leroux, J.-C., Is there a future for cell-penetrating peptides in oligonucleotide delivery? European Journal of Pharmaceutics and Biopharmaceutics, 2013. 85(1): p. 5-11.
50. Salomone, F., Cardarelli, F., Di Luca, M., Boccardi, C., Nifosi, R., Bardi, G., Di Bari, L., Serresi, M., and Beltram, F., A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape. Journal of Controlled Release, 2012. 163(3): p. 293-303.
51. Fei, L., Ren, L., Zaro, J.L., and Shen, W.C., The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides. Journal of Drug Targeting, 2011. 19(8): p. 675-680.
52. Abes, S., Turner, J.J., Ivanova, G.D., Owen, D., Williams, D., Arzumanov, A., Clair, P., Gait, M.J., and Lebleu, B., Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide. Nucleic Acids Research, 2007. 35(13): p. 4495-4502.
53. Crowet, J.-M., Lins, L., Deshayes, S., Divita, G., Morris, M., Brasseur, R., and Thomas, A., Modeling of non-covalent complexes of the cell-penetrating peptide CADY and its siRNA cargo. Biochimica et Biophysica Acta, 2013. 1828(2): p. 499-509.
54. Mo, R.H., Zaro, J.L., and Shen, W.-C., Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy. Molecular Pharmaceutics, 2012. 9(2): p. 299-309.
55. Kwon, E.J., Liong, S., and Pun, S.H., A truncated HGP peptide sequence that retains endosomolytic activity and improves gene delivery efficiencies. Molecular Pharmaceutics, 2010. 7(4): p. 1260-1265.
56. Angeles-Boza, A.M., Erazo-Oliveras, A., Lee, Y.J., and Pellois, J.P., Generation of endosomolytic reagents by branching of cell-penetrating peptides: tools for the delivery of bioactive compounds to live cells in cis or trans. Bioconjugate Chemistry, 2010. 21(12): p. 2164-2167.
57. Chugh, A., Amundsen, E., and Eudes, F., Translocation of cell-penetrating peptides and delivery of their cargoes in triticale microspores. Plant Cell Reports, 2009. 28(5): p. 801-810.
58. Breslow, R., Belvedere, S., Gershell, L., and Leung, D., The chelate effect in binding, catalysis, and chemotherapy. Pure and Applied Chemistry, 2000. 72(3): p. 333-342.
59. Amand, H.L., Norden, B., and Fant, K., Functionalization with C-terminal cysteine enhances transfection efficiency of cell-penetrating peptides through dimer formation. Biochemical and Biophysical Research Communications, 2012. 418(3): p. 469-474.
60. McKenzie, D.L., Kwok, K.Y., and Rice, K.G., A potent new class of reductively activated peptide gene delivery agents. Journal of Biological Chemistry, 2000. 275(14): p. 9970-9977.
61. Khalil, I.A., Futaki, S., Niwa, M., Baba, Y., Kaji, N., Kamiya, H., and Harashima, H., Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Therapy, 2004. 11(7): p. 636-644.
62. Lehto, T., Abes, R., Oskolkov, N., Suhorutsenko, J., Copolovici, D.M., Mager, I., Viola, J.R., Simonson, O.E., Ezzat, K., Guterstam, P., Eriste, E., Smith, C.I., Lebleu, B., Samir El, A., and Langel, U., Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy. Journal of Controlled Release, 2010. 141(1): p. 42-51.
63. Mae, M., El Andaloussi, S., Lundin, P., Oskolkov, N., Johansson, H.J., Guterstam, P., and Langel, U., A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy. Journal of Controlled Release, 2009. 134(3): p. 221-227.
64. Selsted, M.E., Novotny, M.J., Morris, W.L., Tang, Y.Q., Smith, W., and Cullor, J.S., Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. The Journal of Biological Chemistry, 1992. 267(7): p. 4292-4295.
65. Hu, W.W., Lin, Z.W., Ruaan, R.C., Chen, W.Y., Jin, S.L.C., and Chang, Y., A novel application of indolicidin for gene delivery. International Journal of Pharmaceutics, 2013. 456(2): p. 293-300.
66. Marchand, C., Krajewski, K., Lee, H.-F., Antony, S., Johnson, A.A., Amin, R., Roller, P., Kvaratskhelia, M., and Pommier, Y., Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucleic Acids Research, 2006. 34(18): p. 5157-5165.
67. 蔡秉錩, Indolicidin及其類似物之生物活性與直接穿膜特性. 國立中央大學化學工程與材料工程研究所碩士論文, 2012.
68. Shaw, J.E., Alattia, J.R., Verity, J.E., Prive, G.G., and Yip, C.M., Mechanisms of antimicrobial peptide action: studies of indolicidin assembly at model membrane interfaces by in situ atomic force microscopy. Journal of Structural Biology, 2006. 154(1): p. 42-58.
69. Hsu, J.C.Y. and Yip, C.M., Molecular Dynamics Simulations of Indolicidin Association with Model Lipid Bilayers. Biophysical Journal, 2007. 92(12): p. L100-L102.
70. Subbalakshmi, C., Krishnakumari, V., Sitaram, N., and Nagaraj, R., Interaction of indolicidin, a 13-residue peptide rich in tryptophan and proline and its analogues with model membranes. Journal of Biosciences, 1998. 23(1): p. 9-13.
71. Tsai, C.W., Lin, Z.W., Chang, W.F., Chen, Y.F., and Hu, W.W., Development of an indolicidin-derived peptide by reducing membrane perturbation to decrease cytotoxicity and maintain gene delivery ability. Colloids Surf B Biointerfaces, 2018. 165: p. 18-27.
72. Hu, W.W., Yeh, C.C., and Tsai, C.W., The conjugation of indolicidin to polyethylenimine for enhanced gene delivery with reduced cytotoxicity. Journal of Materials Chemistry B, 2018. 6(36): p. 5781-5794.
73. Hu, W.W., Huang, S.C., and Jin, S.L., A novel antimicrobial peptide-derived vehicle for oligodeoxynucleotide delivery to inhibit TNF-α expression. International Journal of Pharmaceutics, 2019. 558: p. 63-71.
74. Loh, X.J., Lee, T.C., Dou, Q., and Deen, G.R., Utilising inorganic nanocarriers for gene delivery. Biomaterials Science, 2016. 4(1): p. 70-86.
75. Kircheis, R., Wightman, L., and Wagner, E., Design and gene delivery activity of modified polyethylenimines. Advanced Drug Delivery Reviews, 2001. 53(3): p. 341-358.
76. Maherani, B., Arab-Tehrany, E., Kheirolomoom, A., Geny, D., and Linder, M., Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids. Biochimie, 2013. 95(11): p. 2018-2033.
77. Exelead. Liposomes and Lipid Nanoparticles as Delivery Vehicles for Personalized Medicine. 2018; Available from: https://www.exeleadbiopharma.com/articles/liposomes-and-lipid-nanoparticles-as-delivery-vehicles-for-personalized-medicine.
78. Glodde, M., Sirsi, S.R., and Lutz, G.J., Physiochemical properties of low and high molecular weight poly(ethylene glycol)-grafted poly(ethylene imine) copolymers and their complexes with oligonucleotides. Biomacromolecules, 2006. 7(1): p. 347-356.
79. Pinnapireddy, S.R., Duse, L., Strehlow, B., Schafer, J., and Bakowsky, U., Composite liposome-PEI/nucleic acid lipopolyplexes for safe and efficient gene delivery and gene knockdown. Colloids and Surfaces B: Biointerfaces, 2017. 158: p. 93-101.
80. Sun, C.S., Wang, C.Y., Chen, B.P., He, R.Y., Liu, G.C., Wang, C.H., Chen, W., Chern, Y., and Huang, J.J., The influence of pathological mutations and proline substitutions in TDP-43 glycine-rich peptides on its amyloid properties and cellular toxicity. PLOS ONE, 2014. 9(8): p. e103644.
81. 臧冠遇, 脂質組成成分對細胞膜物理性質與生物功能的影響. 國立中央大學化學工程與材料工程學系碩士論文, 2015.
82. Chernomordik, L., Non-bilayer lipids and biological fusion intermediates. Chemistry and Physics of Lipids, 1996. 81(2): p. 203-213.
|